BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24681948)

  • 1. A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival.
    Jude JG; Spencer GJ; Huang X; Somerville TDD; Jones DR; Divecha N; Somervaille TCP
    Oncogene; 2015 Mar; 34(10):1253-1262. PubMed ID: 24681948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
    Lima K; Coelho-Silva JL; Kinker GS; Pereira-Martins DA; Traina F; Fernandes PACM; Markus RP; Lucena-Araujo AR; Machado-Neto JA
    Cancer Genet; 2019 Apr; 233-234():56-66. PubMed ID: 31109595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia.
    Sandhöfer N; Metzeler KH; Rothenberg M; Herold T; Tiedt S; Groiß V; Carlet M; Walter G; Hinrichsen T; Wachter O; Grunert M; Schneider S; Subklewe M; Dufour A; Fröhling S; Klein HG; Hiddemann W; Jeremias I; Spiekermann K
    Leukemia; 2015 Apr; 29(4):828-38. PubMed ID: 25322685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.
    Lynch JT; Somerville TD; Spencer GJ; Huang X; Somervaille TC
    Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential profile of PIP4K2A expression in hematological malignancies.
    Lima K; Ribeiro DM; Campos Pde M; Costa FF; Traina F; Saad ST; Sonati Mde F; Machado-Neto JA
    Blood Cells Mol Dis; 2015 Oct; 55(3):228-35. PubMed ID: 26227852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.
    Powell JA; Lewis AC; Zhu W; Toubia J; Pitman MR; Wallington-Beddoe CT; Moretti PA; Iarossi D; Samaraweera SE; Cummings N; Ramshaw HS; Thomas D; Wei AH; Lopez AF; D'Andrea RJ; Lewis ID; Pitson SM
    Blood; 2017 Feb; 129(6):771-782. PubMed ID: 27956387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
    Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
    Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
    Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
    J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase.
    Kremer AN; Bausenwein J; Lurvink E; Kremer AE; Rutten CE; van Bergen CAM; Kretschmann S; van der Meijden E; Honders MW; Mazzeo D; Watts C; Mackensen A; Falkenburg JHF; Griffioen M
    Front Immunol; 2020; 11():381. PubMed ID: 32218783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells.
    Roy A; Chakraborty AR; Nomanbhoy T; DePamphilis ML
    Autophagy; 2023 Sep; 19(9):2464-2484. PubMed ID: 36803256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.
    Feng Y; Wu L
    Biochem Biophys Res Commun; 2017 Feb; 483(2):897-903. PubMed ID: 28082200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells.
    Huang X; Spencer GJ; Lynch JT; Ciceri F; Somerville TD; Somervaille TC
    Leukemia; 2014 May; 28(5):1081-91. PubMed ID: 24166297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
    Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
    Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.
    Kawabata KC; Zong H; Meydan C; Wyman S; Wouters BJ; Sugita M; Goswami S; Albert M; Yip W; Roboz GJ; Chen Z; Delwel R; Carroll M; Mason CE; Melnick A; Guzman ML
    Blood; 2021 Feb; 137(6):812-825. PubMed ID: 32911532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
    Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
    Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.